ID   IBP5_RAT                Reviewed;         271 AA.
AC   P24594;
DT   01-MAR-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-1992, sequence version 1.
DT   02-OCT-2024, entry version 183.
DE   RecName: Full=Insulin-like growth factor-binding protein 5;
DE            Short=IBP-5;
DE            Short=IGF-binding protein 5;
DE            Short=IGFBP-5;
DE   Flags: Precursor;
GN   Name=Igfbp5; Synonyms=Igfbp-5;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 20-53.
RC   TISSUE=Ovary;
RX   PubMed=1709938; DOI=10.1016/s0021-9258(18)99272-0;
RA   Shimasaki S., Shimonaka M., Zhang H.-P., Ling N.;
RT   "Identification of five different insulin-like growth factor binding
RT   proteins (IGFBPs) from adult rat serum and molecular cloning of a novel
RT   IGFBP-5 in rat and human.";
RL   J. Biol. Chem. 266:10646-10653(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Sprague-Dawley;
RX   PubMed=7679898; DOI=10.1006/bbrc.1993.1154;
RA   Zhu X., Ling N., Shimasaki S.;
RT   "Cloning of the rat insulin-like growth factor binding protein-5 gene and
RT   DNA sequence analysis of its promoter region.";
RL   Biochem. Biophys. Res. Commun. 190:1045-1052(1993).
RN   [3]
RP   FUNCTION, AND INDUCTION BY HIGH GLUCOSE.
RX   PubMed=23417767; DOI=10.1530/jme-12-0194;
RA   Song S.E., Kim Y.W., Kim J.Y., Lee D.H., Kim J.R., Park S.Y.;
RT   "IGFBP5 mediates high glucose-induced cardiac fibroblast activation.";
RL   J. Mol. Endocrinol. 50:291-303(2013).
CC   -!- FUNCTION: Multifunctional protein that plays a critical role in
CC       regulating the availability of IGFs to their receptors and thereby
CC       regulates IGF-mediated cellular processes including proliferation,
CC       differentiation, and apoptosis in a cell-type specific manner
CC       (PubMed:23417767). Increases the cell proliferation of osteoblasts,
CC       intestinal smooth muscle cells and neuroblastoma cells (By similarity).
CC       Enhances adhesion and survival of epithelial cells but decreases
CC       adhesion of mesenchymal cells (By similarity). Once secreted, acts as a
CC       major mediator of mTORC1-dependent feedback inhibition of IGF1
CC       signaling (By similarity). Plays also a role in the induction of
CC       extracellular matrix (ECM) production and deposition independently of
CC       its nuclear translocation and binding to IGFs. Acts itself as a growth
CC       factor that can act independently of IGFs to regulate bone formation.
CC       Acts as a ligand for the ROR1 receptor which triggers formation of
CC       ROR1/HER2 heterodimer to enhance CREB oncogenic signaling (By
CC       similarity). {ECO:0000250|UniProtKB:P24593,
CC       ECO:0000250|UniProtKB:Q07079, ECO:0000269|PubMed:23417767}.
CC   -!- SUBUNIT: Interacts with IGF1; this interaction enhances the growth
CC       stimulatory effects of IGF1 on fibroblasts. Interacts with CAV1; this
CC       interaction allows trafficking of IGFBP5 from the plasma membrane to
CC       the nucleus. Interacts with NCL; this interaction is necessary for
CC       IGFBP5 localization to the nucleus. {ECO:0000250|UniProtKB:P24593}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:P24593}.
CC       Cytoplasm {ECO:0000250|UniProtKB:P24593}. Nucleus
CC       {ECO:0000250|UniProtKB:P24593}.
CC   -!- TISSUE SPECIFICITY: Mostly in kidney.
CC   -!- INDUCTION: By high glucose concentrations both at mRNA and protein
CC       levels. {ECO:0000269|PubMed:23417767}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M62781; AAA53533.1; -; mRNA.
DR   EMBL; L08275; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   PIR; JC1463; JC1463.
DR   RefSeq; NP_036949.1; NM_012817.1.
DR   AlphaFoldDB; P24594; -.
DR   SMR; P24594; -.
DR   MINT; P24594; -.
DR   STRING; 10116.ENSRNOP00000023530; -.
DR   MEROPS; I31.952; -.
DR   iPTMnet; P24594; -.
DR   PhosphoSitePlus; P24594; -.
DR   PaxDb; 10116-ENSRNOP00000023530; -.
DR   Ensembl; ENSRNOT00000023530.7; ENSRNOP00000023530.3; ENSRNOG00000017206.7.
DR   Ensembl; ENSRNOT00055016923; ENSRNOP00055013621; ENSRNOG00055010024.
DR   Ensembl; ENSRNOT00060011558; ENSRNOP00060008678; ENSRNOG00060007038.
DR   Ensembl; ENSRNOT00065013665; ENSRNOP00065010142; ENSRNOG00065008601.
DR   GeneID; 25285; -.
DR   KEGG; rno:25285; -.
DR   UCSC; RGD:2876; rat.
DR   AGR; RGD:2876; -.
DR   CTD; 3488; -.
DR   RGD; 2876; Igfbp5.
DR   eggNOG; ENOG502QUPK; Eukaryota.
DR   GeneTree; ENSGT00940000155890; -.
DR   InParanoid; P24594; -.
DR   OMA; YTERCAL; -.
DR   OrthoDB; 5394492at2759; -.
DR   PhylomeDB; P24594; -.
DR   TreeFam; TF331211; -.
DR   Reactome; R-RNO-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-RNO-8957275; Post-translational protein phosphorylation.
DR   PRO; PR:P24594; -.
DR   Proteomes; UP000002494; Chromosome 9.
DR   Bgee; ENSRNOG00000017206; Expressed in esophagus and 19 other cell types or tissues.
DR   ExpressionAtlas; P24594; baseline and differential.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0042567; C:insulin-like growth factor ternary complex; ISO:RGD.
DR   GO; GO:0001968; F:fibronectin binding; ISO:RGD.
DR   GO; GO:0005520; F:insulin-like growth factor binding; IDA:RGD.
DR   GO; GO:0031994; F:insulin-like growth factor I binding; ISO:RGD.
DR   GO; GO:0031995; F:insulin-like growth factor II binding; IBA:GO_Central.
DR   GO; GO:0071320; P:cellular response to cAMP; ISO:RGD.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; ISO:RGD.
DR   GO; GO:0007565; P:female pregnancy; ISO:RGD.
DR   GO; GO:0042593; P:glucose homeostasis; ISO:RGD.
DR   GO; GO:0031069; P:hair follicle morphogenesis; ISO:RGD.
DR   GO; GO:0048009; P:insulin-like growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; IEP:RGD.
DR   GO; GO:0048286; P:lung alveolus development; ISO:RGD.
DR   GO; GO:0060056; P:mammary gland involution; ISO:RGD.
DR   GO; GO:0030336; P:negative regulation of cell migration; ISO:RGD.
DR   GO; GO:0045926; P:negative regulation of growth; ISO:RGD.
DR   GO; GO:0043569; P:negative regulation of insulin-like growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:1901862; P:negative regulation of muscle tissue development; ISO:RGD.
DR   GO; GO:0045668; P:negative regulation of osteoblast differentiation; ISO:RGD.
DR   GO; GO:1904205; P:negative regulation of skeletal muscle hypertrophy; ISO:RGD.
DR   GO; GO:0014912; P:negative regulation of smooth muscle cell migration; ISO:RGD.
DR   GO; GO:0048662; P:negative regulation of smooth muscle cell proliferation; ISO:RGD.
DR   GO; GO:0017148; P:negative regulation of translation; ISO:RGD.
DR   GO; GO:0001649; P:osteoblast differentiation; ISO:RGD.
DR   GO; GO:0043568; P:positive regulation of insulin-like growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:1904754; P:positive regulation of vascular associated smooth muscle cell migration; ISO:RGD.
DR   GO; GO:1904707; P:positive regulation of vascular associated smooth muscle cell proliferation; ISO:RGD.
DR   GO; GO:0001558; P:regulation of cell growth; ISO:RGD.
DR   GO; GO:0040008; P:regulation of growth; ISO:RGD.
DR   GO; GO:0043567; P:regulation of insulin-like growth factor receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0060416; P:response to growth hormone; ISS:AgBase.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0051146; P:striated muscle cell differentiation; ISO:RGD.
DR   GO; GO:0044342; P:type B pancreatic cell proliferation; ISO:RGD.
DR   CDD; cd00191; TY; 1.
DR   Gene3D; 4.10.40.20; -; 1.
DR   Gene3D; 4.10.800.10; Thyroglobulin type-1; 1.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR012213; IGFBP-5.
DR   InterPro; IPR000867; IGFBP-like.
DR   InterPro; IPR022321; IGFBP_1-6_chordata.
DR   InterPro; IPR017891; Insulin_GF-bd_Cys-rich_CS.
DR   InterPro; IPR000716; Thyroglobulin_1.
DR   InterPro; IPR036857; Thyroglobulin_1_sf.
DR   PANTHER; PTHR11551; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN; 1.
DR   PANTHER; PTHR11551:SF4; INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 5; 1.
DR   Pfam; PF00219; IGFBP; 1.
DR   Pfam; PF00086; Thyroglobulin_1; 1.
DR   PRINTS; PR01976; IGFBPFAMILY.
DR   PRINTS; PR01981; IGFBPFAMILY5.
DR   SMART; SM00121; IB; 1.
DR   SMART; SM00211; TY; 1.
DR   SUPFAM; SSF57184; Growth factor receptor domain; 1.
DR   SUPFAM; SSF57610; Thyroglobulin type-1 domain; 1.
DR   PROSITE; PS00222; IGFBP_N_1; 1.
DR   PROSITE; PS51323; IGFBP_N_2; 1.
DR   PROSITE; PS00484; THYROGLOBULIN_1_1; 1.
DR   PROSITE; PS51162; THYROGLOBULIN_1_2; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Direct protein sequencing; Disulfide bond;
KW   Growth factor binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Secreted; Signal.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000255"
FT   CHAIN           20..271
FT                   /note="Insulin-like growth factor-binding protein 5"
FT                   /id="PRO_0000014388"
FT   DOMAIN          22..102
FT                   /note="IGFBP N-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00653"
FT   DOMAIN          188..262
FT                   /note="Thyroglobulin type-1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00500"
FT   REGION          109..129
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        109..125
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         115
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P24593"
FT   DISULFID        26..52
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00653"
FT   DISULFID        29..54
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00653"
FT   DISULFID        37..55
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00653"
FT   DISULFID        44..58
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00653"
FT   DISULFID        66..79
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00653"
FT   DISULFID        73..99
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00653"
FT   DISULFID        191..218
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00500"
FT   DISULFID        229..240
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00500"
FT   DISULFID        242..262
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00500"
SQ   SEQUENCE   271 AA;  30298 MW;  545B4C48F9BB5493 CRC64;
     MVISVVLLLL AACAVPAQGL GSFVHCEPCD EKALSMCPPS PLGCELVKEP GCGCCMTCAL
     AEGQSCGVYT ERCAQGLRCL PRQDEEKPLH ALLHGRGVCL NEKSYGEQTK IERDSREHEE
     PTTSEMAEET YSPKVFRPKH TRISELKAEA VKKDRRKKLT QSKFVGGAEN TAHPRVIPAP
     EMRQESDQGP CRRHMEASLQ EFKASPRMVP RAVYLPNCDR KGFYKRKQCK PSRGRKRGIC
     WCVDKYGMKL PGMEYVDGDF QCHAFDSSNV E
//
